Wockhardt to exit its US generics business
Business

Wockhardt to exit its US generics business

Habil Korakiwala, Chairman, Wockhardt Group | Photo Credit: PAUL NORONHA Drugmaker Wockhardt is realigning its business in the US by focusing on its innovation-driven business,

Tech Query: What Is The Outlook For Samvardhana Motherson International, Arrow Greentech, Wockhardt, Jubilant Foodworks?
Business

Tech Query: What Is The Outlook For Samvardhana Motherson International, Arrow Greentech, Wockhardt, Jubilant Foodworks?

Can I buy Samvardhana Motherson International now for long-term? What is the outlook? Sophia, Kochi Samvardhana Motherson International (₹118.10): The stock is in a downtrend

Wockhardt to exit residual US generics business for “commercial reasons”
Business

Wockhardt to exit residual US generics business for “commercial reasons”

Drugmaker Wockhardt has decided to exit its remaining generics business in the US, for commercial reasons. Over two years ago, the Mumbai-based drugmaker had announced

Nasdaqpicks